AI Scientist Intern
Xaira Therapeutics
AI Scientist Intern
Xaira Therapeutics
AI-powered protein design for therapeutics
About Xaira Therapeutics
Xaira is an innovative biotech startup focused on leveraging AI to transform drug discovery and development. The company is leading the development of generative AI models to design protein and antibody therapeutics, enabling the creation of medicines against historically hard-to-drug molecular targets. It is also developing foundation models for biology and disease to enable better target elucidation and patient stratification. Collectively, these technologies aim to continually enable the identification of novel therapies and to improve success in drug development. Xaira is headquartered in the San Francisco Bay Area, Seattle, and London.
About the Role
As an AI Scientist Intern on our Computational Protein Design team, you will work alongside talented scientists and engineers developing generative AI models for protein and antibody therapeutic design. During your internship, you will contribute to advancing state-of-the-art machine learning models for biology, with a focus on impacting protein/antibody design and drug discovery. You will also have the opportunity to collaborate with interdisciplinary experts in biology, drug discovery, and clinical research.
Responsibilities
Qualifications
Internship Duration
3 months
The expected monthly compensation range is $10,000–$15,000, depending on experience and qualifications. We are open to higher compensation for candidates with exceptional experience or impact. This internship is designed to provide a unique learning experience, offering hands-on exposure to the intersection of AI and computational protein design while allowing you to contribute meaningfully to real-world projects.
AI-powered protein design for therapeutics
Xaira Therapeutics uses artificial intelligence to transform drug discovery and development. It builds a pipeline of protein- and antibody-based therapeutics by combining generative AI models from the IPD lab (notably RFdiffusion and RFantibody) with large, multidimensional biological data. The company designs novel proteins and antibodies from scratch to target difficult, previously undruggable biology, then validates and evolves these molecules through iterative data generation that improves its biological foundation models. Unlike many entrants that offer research services, Xaira aims to own and advance its own therapeutic pipeline across multiple modalities, rather than solely providing platforms. The goal is to deliver effective new medicines faster and with a lower chance of failure by integrating AI-driven design, expansive data, and expert leadership.
Explore more opportunities at Xaira Therapeutics